- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for AstraZeneca PLC (AZN)
| Open: | 51.9800 | Day's Range: | 51.9400 - 52.7200 | Volume: | 3,134,952 |
|---|---|---|---|---|---|
| Previous Close: | 52.3500 | 52wk Range: | 39.7200 - 52.7200 | 1-Yr Rtn: | +35.31% |
Key Statistics for AZN
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 9.6179 |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2013) | 5.4430 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 65,510.18 |
| Shares Outstanding (M) | 1,251.39 |
| 30 Day Average Volume | 1,861,067 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 7.26% |
| Cash Dividend (USD) | 1.9000 |
| Last Dividend | 02/13/2013 |
| 5 Year Dividend Growth | 8.41% |
| Next Earnings Announcement | 08/01/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for AZN
Company Profile & Key Executives for AZN
AstraZeneca PLC is a holding company. The Company, through its subsidiaries, researches, manufactures, and sells pharmaceutical and medical products. AstraZeneca focuses its operations on eight therapeutic areas: Gastrointestinal, Oncology, Cardiovascular, Respiratory, Central Nervous System, Pain Control, Anaesthesia, and Infection.
| Pascal SoriotChief Executive Officer | Simon Jonathan LowthChief Financial Officer |
| Katarina AgeborgChief Compliance Officer | Ruud DobberExec VP:Europe |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
AZN News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page